Efficacy of Fecal Microbiota, Live-jslm (REBYOTA®), Among Patients Exposed to Non–Clostridioides difficile Infection Antibiotics: Post Hoc Subgroup Analysis of a Phase 2 Open-Label Study.

Published in:

Open Forum Infectious Diseases, 2024, v. 11, n. 7, p. 1, doi. 10.1093/ofid/ofae341

By:

• Reveles, Kelly R;
• Gonzales-Luna, Anne J;
• Golan, Yoav;
• Alonso, Carolyn D;
• Guthmueller, Beth;
• Tan, Xing;
• Bidell, Monique R;
• Pokhilko, Victoria;
• Crawford, Carl V;
• Skinner, Andrew M

Publication type:

Article